title: Toxicity of novel C-terminal prion protein fragments and peptides harbouring disease-related C-terminal mutations.
abstract: Mice expressing a C-terminal fragment of the prion protein instead of wild-type prion protein die from massive neuronal degeneration within weeks of birth. The C-terminal region of PrPc (PrP121-231) expressed in these mice has an intrinsic neurotoxicity to cultured neurones. Unlike PrPSc, which is not neurotoxic to neurones lacking PrPc expression, PrP121-231 was more neurotoxic to PrPc-deficient cells. Human mutations E200K and F198S were found to enhance toxicity of PrP121-231 to PrP-knockout neurones and E200K enhanced toxicity to wild-type neurones. The normal metabolic cleavage point of PrPc is approximately amino-acid residue 113. A fragment of PrPc corresponding to the whole C-terminus of PrPc (PrP113-231), which is eight amino acids longer than PrP121-231, lacked any toxicity. This suggests the first eight amino residues of PrP113-121 suppress toxicity of the toxic domain in PrP121-231. Addition to cultures of a peptide (PrP112-125) corresponding to this region, in parallel with PrP121-231, suppressed the toxicity of PrP121-231. These results suggest that the prion protein contains two domains that are toxic on their own but which neutralize each other's toxicity in the intact protein. Point mutations in the inherited forms of disease might have their effects by diminishing this inhibition.
authors.affiliation: Department of Biochemistry, Cambridge University, UK.
authors.forename: M
authors.initials: M
authors.lastname: Daniels
authors.forename: G M
authors.initials: GM
authors.lastname: Cereghetti
authors.forename: D R
authors.initials: DR
authors.lastname: Brown
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D002478:Cells, Cultured; D002531:Cerebellum / Q000166:cytology / Q000187:drug effects; D002942:Circular Dichroism; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008969:Molecular Sequence Data; D009154:Mutation; D009410:Nerve Degeneration / Q000209:etiology / Q000473:pathology; D009457:Neuroglia / Q000187:drug effects; D009474:Neurons / Q000187:drug effects; D009498:Neurotoxins / Q000737:chemistry / Q000235:genetics / Q000633:toxicity; D010446:Peptide Fragments / Q000737:chemistry / Q000235:genetics / Q000633:toxicity; D018621:PrPC Proteins / Q000737:chemistry / Q000235:genetics* / Q000633:toxicity*; D017096:Prion Diseases / Q000209:etiology / Q000473:pathology
chemical_list: D009498:Neurotoxins; D010446:Peptide Fragments; D018621:PrPC Proteins